Business
Acadia Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026
SAN DIEGO, April 15, 2026--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report first quarter 2026 financial results on Wednesday, May 6, 2026, after the close of the U.S. financial markets. Acadia’s management team will also host a conference call and webcast on May 6, 2026, at 4:30 p.m. Eastern Time.
About this update from Acadia Pharmaceuticals Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":800,"height":307,"url":"https://media.zenfs.com/en/business-wire.com/9aa169fa75d47bbc641e20e683e9dad8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/gUIK1V.tdfBd0JOOKDIDfQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM2OA--/https://media.zenfs.com/en/business-wire.com/9aa169fa75d47bbc641e20e683e9dad8","width":800,"height":307},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/8pJpjR3Q6HQ3DyJ4AqMnvg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE2MDA7aD02MTQ-/https://media.zenfs.com/en/business-wire.com/9aa169fa75d47bbc641e20e683e9dad8","width":800,"height":307}},"lazy":false},{"type":"text","content":"Company to host conference call and webcast on Wednesday, May 6, 2026, at 4:30 p.m. Eastern Time","length":96,"tagName":"p","attribs":{}},{"type":"text","content":"SAN DIEGO, April 15, 2026--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report first quarter 2026 financial results on Wednesday, May 6, 2026, after the close of the U.S. financial markets. Acadia’s management team will also host a conference call and webcast on May 6, 2026, at 4:30 p.m. Eastern Time.","length":346,"tagName":"p"},{"type":"text","content":"The conference call will be available on Acadia’s website, acadia.com under the investors section and will be archived there until August 15, 2026. The conference call may also be accessed by registering for the call here. Once registered, participants will receive an email with the dial-in number and unique PIN number to use for accessing the call.","length":351,"tagName":"p"},{"type":"text","content":"About Acadia Pharmaceuticals","length":28,"tagName":"p"},{"type":"text","content":"Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs....